Our Portfolio of Healthcare Investments

We partner with world-class management teams to build best-of-breed businesses

view all


Produces the Impella product line, the world's smallest, minimally invasive, high performance micro blood pump


Rapidly growing pan-Latin American specialty pharmaceutical company, focused on oncology and critical care drugs


International orthobiologics company focused on bone growth stimulation and joint pain therapies

EUSA Pharma

Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care

  • "Our collaboration with Essex Woodlands goes beyond that of a typical investment relationship. Essex Woodlands has become a partner and advisor to Abiomed and we value the strategic insight and guidance we receive from the team members at Essex Woodlands on various investment and business decisions."


    Michael R. Minogue

    Chairman, President and CEO, Abiomed
  • "Essex Woodlands has been an invaluable partner for Biotoscana. Essex‚Äôs deep healthcare expertise, industry relationships and strategic insights are helping Biotoscana achieve its mission of being the high growth specialty pharma company in Latin America."


    Mariano Garcia-Valino

    Chief Executive Officer, Biotoscana
  • "Essex Woodlands is more than an investor in our business, they are truly a collaborative partner. They challenge our thinking to help us become a better organization, plus offer expertise and guidance that helped us emerge from a small spin-out company to a global player in the orthobiologics market. We look forward to continuing this close relationship as we expand our product offerings and grow our company."


    Anthony P. Bihl, III

    Chief Executive Officer, Bioventus
  • "Essex Woodlands is not so much an Investor as a Partner in building successful businesses as was my experience with EUSA."


    Bryan Morton

    Chief Executive Officer, EUSA Pharma
Image Map